These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

733 related articles for article (PubMed ID: 28074282)

  • 1. Unique findings of subependymal giant cell astrocytoma within cortical tubers in patients with tuberous sclerosis complex: a histopathological evaluation.
    Katz JS; Frankel H; Ma T; Zagzag D; Liechty B; Zeev BB; Tzadok M; Devinsky O; Weiner HL; Roth J
    Childs Nerv Syst; 2017 Apr; 33(4):601-607. PubMed ID: 28074282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different MRI-defined tuber types in tuberous sclerosis complex: Quantitative evaluation and association with disease manifestations.
    Jesmanas S; Norvainytė K; Gleiznienė R; Šimoliūnienė R; Endzinienė M
    Brain Dev; 2018 Mar; 40(3):196-204. PubMed ID: 29258718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience using mTOR inhibitors for subependymal giant cell astrocytoma in tuberous sclerosis complex at a single facility.
    Tomoto K; Fujimoto A; Inenaga C; Okanishi T; Imai S; Ogai M; Fukunaga A; Nakamura H; Sato K; Obana A; Masui T; Arai Y; Enoki H
    BMC Neurol; 2021 Mar; 21(1):139. PubMed ID: 33784976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian target of rapamycin inhibitors for intractable epilepsy and subependymal giant cell astrocytomas in tuberous sclerosis complex.
    Cardamone M; Flanagan D; Mowat D; Kennedy SE; Chopra M; Lawson JA
    J Pediatr; 2014 May; 164(5):1195-200. PubMed ID: 24518170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of mTOR inhibition on obstructive hydrocephalus in patients with tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).
    Weidman DR; Palasamudram S; Zak M; Whitney R; McCoy B; Bouffet E; Taylor M; Shroff M; Bartels U
    J Neurooncol; 2020 May; 147(3):731-736. PubMed ID: 32285309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subependymal giant cell astrocytoma: a lesion with activated mTOR pathway and constant expression of glutamine synthetase.
    Buccoliero AM; Caporalini C; Giordano F; Mussa F; Scagnet M; Moscardi S; Baroni G; Genitori L; Taddei GL
    Clin Neuropathol; 2016; 35(5):295-301. PubMed ID: 27390104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron and microscopic study.
    Hirose T; Scheithauer BW; Lopes MB; Gerber HA; Altermatt HJ; Hukee MJ; VandenBerg SR; Charlesworth JC
    Acta Neuropathol; 1995; 90(4):387-99. PubMed ID: 8546029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single and staged laser interstitial thermal therapy ablation for cortical tubers causing refractory epilepsy in pediatric patients.
    Tovar-Spinoza Z; Ziechmann R; Zyck S
    Neurosurg Focus; 2018 Sep; 45(3):E9. PubMed ID: 30173608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated subependymal giant cell astrocytoma (SEGA) in the absence of clinical tuberous sclerosis: two case reports and literature review.
    Cobourn KD; Chesney KM; Mueller K; Fayed I; Tsering D; Keating RF
    Childs Nerv Syst; 2024 Jan; 40(1):73-78. PubMed ID: 37658938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraventricular lesions in tuberous sclerosis complex: a possible association with the caudate nucleus.
    Katz JS; Milla SS; Wiggins GC; Devinsky O; Weiner HL; Roth J
    J Neurosurg Pediatr; 2012 Apr; 9(4):406-13. PubMed ID: 22462706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging diagnosis of subependymal giant cell astrocytomas in follow-up of children with tuberous sclerosis complex: should we always use contrast enhancement?
    Gaillard AL; Crombé A; Jecko V; Bessou P; Havez M; Pédespan JM; Van Gils J; Chateil JF
    Pediatr Radiol; 2020 Sep; 50(10):1397-1408. PubMed ID: 32671416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuber Brain Proportion Determines Epilepsy Onset in Children With Tuberous Sclerosis Complex.
    Zhang F; Xie L; He X; Song X; Zheng H; Wang L; Jiang L
    Pediatr Neurol; 2022 Apr; 129():39-45. PubMed ID: 35217276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological Findings of a Subependymal Giant Cell Astrocytoma Following Treatment With Rapamycin.
    Cheng S; Hawkins C; Taylor MD; Bartels U
    Pediatr Neurol; 2015 Sep; 53(3):238-242.e1. PubMed ID: 26173783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The outcome of surgical management of subependymal giant cell astrocytoma in tuberous sclerosis complex.
    Amin S; Carter M; Edwards RJ; Pople I; Aquilina K; Merrifield J; Osborne JP; O'Callaghan FJ
    Eur J Paediatr Neurol; 2013 Jan; 17(1):36-44. PubMed ID: 23183057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the growth rate of subependymal giant cell astrocytoma and age in patients with tuberous sclerosis complex.
    Tsai JD; Wei CC; Tsao TF; Hsiao YP; Tsai HJ; Yang SH; Tsai ML; Sheu JN
    Childs Nerv Syst; 2016 Jan; 32(1):89-95. PubMed ID: 26552385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-level response rates of mTor inhibition in tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).
    Weidman DR; Pole JD; Bouffet E; Taylor MD; Bartels U
    Pediatr Blood Cancer; 2015 Oct; 62(10):1754-60. PubMed ID: 25929843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurosurgical aspects in the treatment of children with tuberous sclerosis complex].
    Roth J; Fried I; Constantini S
    Harefuah; 2014 Jan; 153(1):43-7, 63. PubMed ID: 24605407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The coding and non-coding transcriptional landscape of subependymal giant cell astrocytomas.
    Bongaarts A; van Scheppingen J; Korotkov A; Mijnsbergen C; Anink JJ; Jansen FE; Spliet WGM; den Dunnen WFA; Gruber VE; Scholl T; Samueli S; Hainfellner JA; Feucht M; Kotulska K; Jozwiak S; Grajkowska W; Buccoliero AM; Caporalini C; Giordano F; Genitori L; Coras R; Blümcke I; Krsek P; Zamecnik J; Meijer L; Scicluna BP; Schouten-van Meeteren AYN; Mühlebner A; Mills JD; Aronica E
    Brain; 2020 Jan; 143(1):131-149. PubMed ID: 31834371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical timing of the subependymal giant cell astrocytoma (SEGA) with the patients of tuberous sclerosis complex.
    Ekici MA; Kumandas S; Per H; Ekici A; Tucer B; Gumus H; Canoz O; Kurtsoy A
    Turk Neurosurg; 2011; 21(3):315-24. PubMed ID: 21845566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012.
    Roth J; Roach ES; Bartels U; Jóźwiak S; Koenig MK; Weiner HL; Franz DN; Wang HZ
    Pediatr Neurol; 2013 Dec; 49(6):439-44. PubMed ID: 24138953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.